Information Technology · Services-Help Supply Services

AMN AMN HEALTHCARE SERVICES INC SEC Filings & Insider Trading Activity 2026

company
CIK 1142750111 filings
Russell 2000

AMN at a glance

AMN HEALTHCARE SERVICES INC (AMN, SEC CIK 1142750) filed its latest 10-K annual report on February 20, 2026, a 10-Q quarterly report on November 6, 2026, an 8-K current report on November 5, 2026 and Form 4 insider filings as recently as October 15, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), AMN HEALTHCARE SERVICES INC (AMN) reported revenue of $2.7 billion (down 8.5% from FY2024) and a net loss of $95.7 million. Diluted EPS was -$2.48.
  • As of September 30, 2026, 30 institutional investment managers tracked by SignalX reported holding AMN HEALTHCARE SERVICES INC (AMN) shares worth $899.8 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by FOLETTA MARK G on June 15, 2026 of 2,000 shares at $31.07 per share.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$2.7B
−8.5% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
30 funds
$899.8M · +0 vs prior quarter
Latest 8-K
Nov 5, 2026
Item 2.02

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material changes to risk factors disclosed in the 2025 Annual Report
  • Carried-forward risk: unknown or currently immaterial factors could adversely affect operating results
  • Market risk: general economic conditions could materially affect financial condition
  • Financial risk: adverse factors could materially reduce cash flows

Management Discussion & Analysis

  • Q3 revenue $717.3M, up 13% from $634.5M YoY, driven by nurse and allied solutions
  • Gross margin 31.9% vs 29.1%; operating margin 7.0% vs 7.5%; net margin 4.7% vs 4.6% YoY
  • Best segment: nurse and allied revenue $460.0M, up 27%; margin 30.9% vs 24.1%
  • Worst segment: technology and workforce revenue $86.1M, down 9%; margin 47.7% vs 51.5%
  • Operating cash flow $285.0M through nine months vs $193.9M; cash increased $208.2M, with $10.7M stock repurchases
  • Outlook: operations expected funded for next 12 months; immigration policy, language-services pricing, and VMS utilization headwinds

AI summary of the AMN 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 5, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • AMN Healthcare reported fiscal quarter results for the period ended September 30, 2026
  • Detailed financial results and management commentary are contained in Exhibit 99.1

Item EX-99.1: Item EX-99.1

  • Q3 revenue $717.3M, up 13%, and adjusted EBITDA $93.6M, up 63%, exceeding company guidance
  • Adjusted EPS $1.16 versus $0.39, while GAAP diluted EPS rose to $0.83 from $0.76
Filed Aug 6, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q2 revenue $673.2M, up 2%; adjusted EBITDA $73.4M, up 26%, with margin reaching 10.9%
  • GAAP diluted EPS $0.53 versus $(3.02); adjusted EPS $0.77 versus $0.30, reflecting significant earnings normalization

Item 2.02: Results of Operations and Financial Condition

  • AMN Healthcare reported fiscal Q2 2026 results for the quarter ended June 30, 2026
  • Detailed financial results and management commentary are contained in Exhibit 99.1:VEVENT
Filed May 7, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q1 2026 results released for quarter ended March 31, 2026
  • Full financial results and management commentary available in Exhibit 99.1

AI summaries of AMN 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for AMN

Don't miss the next AMN filing

  • Alerts as it files. A push when AMN files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut AMN, by share count.
  • Ask anything. An AI agent that reads every AMN filing and answers with sources.

AMN alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Laughlin Whitney MFOct 15, 2026$37.66
Laughlin Whitney MMOct 15, 2026-
Laughlin Whitney MMOct 15, 2026-
Hagan Mark ChristopherMOct 15, 2026-
Hagan Mark ChristopherFOct 15, 2026$37.66
Hagan Mark ChristopherMOct 15, 2026-
Laughlin Whitney MMSep 15, 2026-
Laughlin Whitney MMSep 15, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$3.0B$2.7B
Gross Profit-$919.4M$774.1M
Operating Income--$102.7M-$55.5M
Net Income--$147.0M-$95.7M
Gross Margin-30.8%28.3%
Op. Margin--3.4%-2.0%
Net Margin--4.9%-3.5%
Balance Sheet
Total Assets$2.9B$2.4B$2.1B
Equity$831.3M$706.6M$642.1M
ROE--20.8%-14.9%
Per Share
EPS-$-3.85$-2.48
Cash Flow
Operating CF-$320.4M$269.5M
CapEx-$80.9M$35.6M

Source: XBRL data in AMN HEALTHCARE SERVICES INC (AMN)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate AMN share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
AMN shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202630$899.8M
Q2 202630$785.4M
Q1 202630$404.7M
Q4 202527$347.4M
Q3 202528$425.5M
Q2 202528$463.1M
Q1 202525$382.0M
Q4 202423$334.7M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 221 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

AMN filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
10-QNov 6, 2026Analysis
8-KNov 5, 2026Analysis-
4Oct 15, 2026--
4Oct 15, 2026--
4Sep 16, 2026--
SC 13GAug 13, 2026-
10-QAug 7, 2026Analysis
8-KAug 6, 2026Analysis-
4Jul 9, 2026--
4Jun 17, 2026--
10-QMay 8, 2026Analysis
8-KMay 7, 2026Analysis
4May 4, 2026--
4May 4, 2026--
4May 4, 2026--
4May 4, 2026--
4May 4, 2026--
4May 4, 2026--
4May 4, 2026--
8-KMay 4, 2026Analysis-
4May 4, 2026--
4May 4, 2026--
SC 13GApr 29, 2026-
10-KFeb 20, 2026-
8-KFeb 19, 2026-

Related Information Technology companies

All Information Technology →

AMN SEC filings: frequently asked questions

Which institutions hold AMN stock?

As of September 30, 2026, the largest AMN HEALTHCARE SERVICES INC (AMN) holders among the 13F filers tracked by SignalX were BlackRock ($254.0 million), Morgan Stanley ($70.9 million), Ameriprise Financial ($69.6 million), State Street Corp ($61.8 million), Vanguard Capital Management LLC ($61.3 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was AMN's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), AMN HEALTHCARE SERVICES INC (AMN) reported revenue of $2.7 billion (down 8.5% from FY2024) and a net loss of $95.7 million. Diluted EPS was -$2.48. The figures come from the XBRL data in the 10-K.

What did AMN report in its latest 8-K?

AMN HEALTHCARE SERVICES INC (AMN) filed an 8-K on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). AMN Healthcare reported fiscal quarter results for the period ended September 30, 2026.

What are the latest AMN SEC filings?

AMN HEALTHCARE SERVICES INC (AMN) filed its latest 10-K annual report on February 20, 2026, a 10-Q quarterly report on November 6, 2026, an 8-K current report on November 5, 2026 and a Form 4 insider filing on October 15, 2026.

What is AMN's SEC CIK number?

AMN HEALTHCARE SERVICES INC (AMN)'s SEC Central Index Key (CIK) is 1142750. EDGAR lists every AMN filing under that number.

Ask anything about AMN

The research agent reads AMN's filings, financials, insider trades and 13F holders, then answers with sources.